Clinical Trial Update: Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection. [Phase 2]

View source ↗

Summary

A completed Phase 2 pilot clinical trial evaluating CVT-E002 for pediatric upper respiratory tract infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Respiratory Infection

Drugs mentioned

• CVT-E002

Snippet

Sponsor: CV Technologies | Conditions: Upper Respiratory Infection | Phase 2 | Status: COMPLETED